3.1 Disease activity index:
DAI is an applicable guide to quantify the severity of intestinal
inflammation. A-A group showed a significant increase in DAI compared to
the control group. All treated groups showed significant lower DAI
compared to A-A group. Liraglutide, Sitagliptin, Sulfasalazine, CLS and
CSS groups showed a mean DAI of (2.3 ± 0.5), (2.0 ± 0.3), (2.6 ± 0.4),
(1.9 ± 0.5) and (1.9 ± 0.2) respectively, compared to A-A group (5.2±
0.4).